199 related articles for article (PubMed ID: 717877)
1. Venezuelan equine encephalomyelitis vaccine (strain TC-83): a field study.
Baker EF; Sasso DR; Maness K; Prichard WD; Parker RL
Am J Vet Res; 1978 Oct; 39(10):1627-31. PubMed ID: 717877
[TBL] [Abstract][Full Text] [Related]
2. Study of homologous and heterologous antibody response in California horses vaccinated with attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
Ferguson JA; Reeves WC; Milby MM; Hardy JL
Am J Vet Res; 1978 Mar; 39(3):371-6. PubMed ID: 637386
[TBL] [Abstract][Full Text] [Related]
3. A field study of persistence of antibodies in California horses vaccinated against western, eastern, and Venezuelan equine encephalomyelitis.
Vanderwagen LC; Pearson JL; Franti CE; Tamm EL; Riemann HP; Behymer DE
Am J Vet Res; 1975 Nov; 36(11):1567-71. PubMed ID: 1190598
[TBL] [Abstract][Full Text] [Related]
4. Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines.
Ferguson JA; Reeves WC; Hardy JL
Am J Vet Res; 1977 Apr; 38(4):425-30. PubMed ID: 851275
[TBL] [Abstract][Full Text] [Related]
5. Cross-protective immunity between equine encephalomyelitis viruses in equids.
Walton TE; Jochim MM; Barber TL; Thompson LH
Am J Vet Res; 1989 Sep; 50(9):1442-6. PubMed ID: 2552875
[TBL] [Abstract][Full Text] [Related]
6. Immune response of horses after simultaneous or sequential vaccination against eastern, western, and Venezuelan equine encephalomyelitis.
Jochim MM; Barber TL
J Am Vet Med Assoc; 1974 Oct; 165(7):621-5. PubMed ID: 4422323
[No Abstract] [Full Text] [Related]
7. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
[TBL] [Abstract][Full Text] [Related]
8. Arbovirus investigations in Argentina, 1977-1980. IV. Serologic surveys and sentinel equine program.
Monath TP; Sabattini MS; Pauli R; Daffner JF; Mitchell CJ; Bowen GS; Cropp CB
Am J Trop Med Hyg; 1985 Sep; 34(5):966-75. PubMed ID: 2863991
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses.
Barber TL; Walton TE; Lewis KJ
Am J Vet Res; 1978 Apr; 39(4):621-5. PubMed ID: 646197
[TBL] [Abstract][Full Text] [Related]
10. Experimental infection of horses with an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
Walton TE; Alvarez O; Buckwalter RM; Johnson KM
Infect Immun; 1972 May; 5(5):750-6. PubMed ID: 4637604
[TBL] [Abstract][Full Text] [Related]
11. In mice the efficiency of immunization with Venezuelan Equine Encephalomyelitis virus TC-83 is transiently increased by dehydroepiandrosterone.
Negrette B; Bonilla E; Valero N; Giraldoth D; Medina-Leendertz S; Añez F
Invest Clin; 2001 Dec; 42(4):235-40. PubMed ID: 11787268
[TBL] [Abstract][Full Text] [Related]
12. Possible evidence for interference with Venezuelan equine encephalitis virus vaccination of equines by pre-existing antibody to Eastern or Western Equine encephalitis virus, or both.
Calisher CH; Sasso DR; Sather GE
Appl Microbiol; 1973 Oct; 26(4):485-8. PubMed ID: 4751797
[TBL] [Abstract][Full Text] [Related]
13. Persistence of neutralizing antibody in Equidae vaccinated with Venezuelan equine encephalomyelitis vaccine strain TC-83.
Walton TE; Johnson KM
J Am Vet Med Assoc; 1972 Oct; 161(8):916-8. PubMed ID: 5074268
[No Abstract] [Full Text] [Related]
14. Epidemic Venezuelan equine encephalitis in North America in 1971: vertebrate field studies.
Sudia WD; McLean RG; Newhouse VF; Johnston JG; Miller DL; Trevino H; Bowen GS; Sather G
Am J Epidemiol; 1975 Jan; 101(1):36-50. PubMed ID: 1119481
[TBL] [Abstract][Full Text] [Related]
15. Duration of immunity of horses vaccinated with strain TC-83 Venezuelan equine encephalomyelitis virus vaccine.
Walton TE; Luedke AJ; Jochim MM; Crenshaw GL; Ferguson JA
Proc Annu Meet U S Anim Health Assoc; 1973; (77):196-202. PubMed ID: 4534711
[No Abstract] [Full Text] [Related]
16. Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies.
Rosas CT; Paessler S; Ni H; Osterrieder N
Am J Trop Med Hyg; 2008 Jan; 78(1):83-92. PubMed ID: 18187789
[TBL] [Abstract][Full Text] [Related]
17. Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine.
Burke DS; Ramsburg HH; Edelman R
J Infect Dis; 1977 Sep; 136(3):354-9. PubMed ID: 903673
[TBL] [Abstract][Full Text] [Related]
18. Immune interference after sequential alphavirus vaccine vaccinations.
Pittman PR; Liu CT; Cannon TL; Mangiafico JA; Gibbs PH
Vaccine; 2009 Aug; 27(36):4879-82. PubMed ID: 19576665
[TBL] [Abstract][Full Text] [Related]
19. Clinical studies of an attenuated virus cell culture venezuelan equine encephalomyelitis vaccine.
Sampson GR; Elliston NG; Miyat JA; Grueter HP; Gillespie JR; Rathmacher RP
Mod Vet Pract; 1973 Aug; 54(8):19, 21-2. PubMed ID: 4803525
[No Abstract] [Full Text] [Related]
20. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV
Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
